Abiraterone acetate, an oral agent, acts as a selective and irreversible inhibitor of the CYP17A1 enzyme, which plays a critical role in the enzymatic conversion of steroid precursors such as pregnenolone and progesterone within the testes, adrenal glands, and tumor microenvironment [93]. Here, CYP17A1 is linked to neoplasm.